ACAD
36.63
-1.54
-4.03%
AEMD
7.59
+0.54
+7.66%
APRI
1.7
+0.35
+25.93%
ARNA
2.71
0.00
0.00%
ATEC
0.575
+0.035
+6.481%
CNAT
3.93
-0.12
-2.96%
CRXM
0.37
0.00
0.00%
CYTX
0.362
+0.047
+14.9524%
DXCM
94.14
-0.05
-0.05%
GNMK
10.34
+0.32
+3.19%
HALO
17.46
-0.95
-5.16%
ILMN
197.61
-4.09
-2.03%
INNV
0.148
0.00
0.00%
INO
7.49
-0.24
-3.10%
ISCO
3.9
-0.08
-2.01%
ISIS
50.18
-1.36
-2.64%
LGND
91.94
-3.1
-3.26%
LPTN
0.23
+0.01
+2.22%
MBVX
1.75
+0.06
+3.86%
MEIP
1.82
+0.09
+5.20%
MNOV
2.95
+0.01
+0.34%
MRTX
25.82
-0.84
-3.15%
MSTX
0.485
+0.015
+3.191%
NBIX
46.38
-0.29
-0.62%
NUVA
52.72
-1.03
-1.92%
ONCS
5.38
+0.18
+3.46%
ONVO
2.73
+0.19
+7.48%
OREX
2.77
-0.12
-4.15%
OTIC
22.67
-0.83
-3.53%
QDEL
20.59
+0.14
+0.68%
RCPT
231.96
0.00
0.00%
RGLS
8.33
+0.06
+0.73%
RMD
51.94
-0.53
-1.01%
SCIE
0.014
0.00
-2.7586%
SPHS
0.9
+0.01
+1.12%
SRNE
12.68
-0.97
-7.11%
TROV
5.95
-0.38
-6.00%
VICL
0.59
+0.00
+0.0339%
VOLC
18
0.00
0.00%
ZGNX
19.22
+0.81
+4.40%
ACAD
36.63
-1.54
-4.03%
AEMD
7.59
+0.54
+7.66%
APRI
1.7
+0.35
+25.93%
ARNA
2.71
0.00
0.00%
ATEC
0.575
+0.035
+6.481%
CNAT
3.93
-0.12
-2.96%
CRXM
0.37
0.00
0.00%
CYTX
0.362
+0.047
+14.9524%
DXCM
94.14
-0.05
-0.05%
GNMK
10.34
+0.32
+3.19%
HALO
17.46
-0.95
-5.16%
ILMN
197.61
-4.09
-2.03%
INNV
0.148
0.00
0.00%
INO
7.49
-0.24
-3.10%
ISCO
3.9
-0.08
-2.01%
ISIS
50.18
-1.36
-2.64%
LGND
91.94
-3.1
-3.26%
LPTN
0.23
+0.01
+2.22%
MBVX
1.75
+0.06
+3.86%
MEIP
1.82
+0.09
+5.20%
MNOV
2.95
+0.01
+0.34%
MRTX
25.82
-0.84
-3.15%
MSTX
0.485
+0.015
+3.191%
NBIX
46.38
-0.29
-0.62%
NUVA
52.72
-1.03
-1.92%
ONCS
5.38
+0.18
+3.46%
ONVO
2.73
+0.19
+7.48%
OREX
2.77
-0.12
-4.15%
OTIC
22.67
-0.83
-3.53%
QDEL
20.59
+0.14
+0.68%
RCPT
231.96
0.00
0.00%
RGLS
8.33
+0.06
+0.73%
RMD
51.94
-0.53
-1.01%
SCIE
0.014
0.00
-2.7586%
SPHS
0.9
+0.01
+1.12%
SRNE
12.68
-0.97
-7.11%
TROV
5.95
-0.38
-6.00%
VICL
0.59
+0.00
+0.0339%
VOLC
18
0.00
0.00%
ZGNX
19.22
+0.81
+4.40%
Home » Archive by Category

Syndication

Senior Director, Regulatory Affairs – Sequoia – San Diego, CA

August 28, 2015 – 8:05 pm

Scientific degree (chemistry or biology) plus a minimum 10-15 years’ experience in a clinical stage cell therapy, pharmaceutical or biotechnology company….
From Sequoia – 29 Aug 2015 03:05:41 GMT
– View all San Diego jobs

Salk Institute For Biological Studies-Research Assistant II/III-E820 (La Jolla)

August 28, 2015 – 4:50 pm

Reporting to the Principal Investigator (PI), the Research Assistant II position is part of a research team focused on projects at the intersection of stem cells, microenvironment, development, and cancer. Under the direction of the PI the position w […

Project Analyst (Science Background) (Sorrento Valley)

August 28, 2015 – 4:26 pm

Top Three Skills:
ELISA, biochemistry, Good Laboratory Practices (GLP), following SOP’s, method develoment ELISA
Job Description:
Develop and validate analytical assays (mainly ELISA) to meet final requirements
of QAU review and release.
Perform […

Bioinformatics Scientist/Senior Scientist – Sequenom – San Diego, CA

August 28, 2015 – 4:13 pm

Minimum of 3 years work experience, preferably in a commercial biotechnology setting. We currently have a great opportunity for a Bioinformatics Scientist who…
From Sequenom – 28 Aug 2015 23:13:18 GMT
– View all San Diego jobs

Copy Writer/Editor III (Biotech) at Aquent (Carlsbad, CA)

August 28, 2015 – 4:12 pm

We’re a large, internal creative services team seeking a strong concept copywriter with agency experience, an ability to distill complex technical content into eye-catching yet meaningful copy, and a willingness to hit the ground running.

Validation Engineer – Hologic – San Diego, CA

August 28, 2015 – 3:18 pm

4 years of validation experience in a diagnostic, medical device, biotech or pharmaceutical company. Experience with electronic document management systems….
From Hologic – 28 Aug 2015 22:18:36 GMT
– View all San Diego jobs

Entry level lab assistant (San Diego)

August 28, 2015 – 3:06 pm

Top three skills: Buffer/reagent preparation, wash glassware, lab support
Job description:
1. Responsible for preparation and documentation of reagents.
2. Responsible for general lab safety with regard to employees and clients.
3. Fill pipette t […

CytomX Files Registration Statement for Proposed Initial Public Offering

August 28, 2015 – 3:04 pm

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2015 /PRNewswire/ — CytomX Therapeutics, Inc., a biopharmaceutical company developing Probody™ therapeutics for the treatment of cancer, today announced the filing of a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. CytomX intends to list its common stock under the symbol “CTMX” on the NASDAQ Global Market.

BofA Merrill Lynch, Jefferies LLC and Cowen and Company LLC will act as joint book-running managers for the offering.  Oppenheimer & Co. will serve as manager for the offering. 

A registration statement relating to these securities has been filed with the SEC, but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained from BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attention: Prospectus Department, or by email at dg.prospectus_requests@baml.com; Jefferies LLC, Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com; or Cowen and Company, LLC, c/o Broadridge Financial Services, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 631-274-2806 or by fax at 631-254-7140.

Media Contacts:
Canale Communications
Ian Stone
ian@canalecomm.com
619-849-5388

Investor Contacts:
Trout Group
Pete Rahmer
prahmer@troutgroup.com
646-378-2973

 

SOURCE CytomX Therapeutics

Manufacturing Technician- Microbiology (Sorrento Valley)

August 28, 2015 – 2:33 pm

We are a well-established biotech company in Sorrento Valley. Our team is in need of a Manufacturing Technician with knowledge of Microbiology.
This will be a long-term opportunity
Monday- Friday, 7 AM- 3:30 PM
$15-$16/hr DOE
The Manufacturing Te […

Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Six Months Ended June 30, 2015

August 28, 2015 – 1:30 pm

CARLSBAD, CALIFORNIA–(Marketwired – Aug. 28, 2015) -